These findings underscore FGF21’s role in mediating crosstalk between mature adipocytes and immune cells in white adipose tissue and suggest that targeting FGF21 signaling and its downstream metabolites could offer a potential therapeutic approach for GDM in humans. Here, FGF21 is linked to gestational diabetes.